Dihydroboldenone (DHB): What the Research Shows

Dihydroboldenone (DHB, also called 1-testosterone) is a potent non-aromatizing injectable anabolic with a near-total absence of human pharmacokinetic data. It is a 5-alpha-reduced derivative of boldenone, which means it cannot convert to estrogen, producing a dry, hard anabolic effect. Compared to trenbolone it has a reportedly milder side-effect profile (no night sweats, no prolactin issues, no severe cough), and compared to Primobolan it tends to produce more dramatic strength and lean mass gains, though the evidence base for all of these claims is thin. The half-life is modeled at roughly 9 days, supporting twice-weekly injections of the cypionate ester.

What DHB is

Dihydroboldenone (DHB) is a DHT-derived analog of boldenone. The 5-alpha-reduction changes the character of the molecule. Boldenone (Equipoise) aromatizes weakly and has a reputation for slow, steady gains with mild side effects. DHB cannot aromatize at all because the A-ring is already saturated at the 5-alpha position, so there is no pathway to estrogen.

This puts DHB in the same broad family as other dry, non-estrogenic compounds: Primobolan, Masteron, and trenbolone. Users report hard, dense gains without water retention, which is the main appeal.

It is almost always supplied as 1-testosterone cypionate, meaning the cypionate ester controls release rate. This is why the modeled half-life is long (roughly 216 hours, or 9 days) and why twice-weekly dosing is the documented community protocol.

Pharmacokinetics (such as they are)

Here is where honesty matters. The dataset records these values for DHB:

• Half-life: ~216 hours (roughly 9 days), modeled anecdotally
• Cmax: 69.9 ng/dL serum peak
• Bioavailability: modeled at 100% (injectable)
• Default dose: 200 mg, with a typical range of 100 to 300 mg
• Injection frequency: 2 times per week
• Hepatotoxicity: rated mild
• Aromatization: none (5-alpha-reduced)

The source note in the dataset says it plainly: “1-testosterone (DHB) has limited published PK data.” There are no controlled human pharmacokinetic studies establishing the true half-life, clearance, or steady-state behavior. The 9-day figure comes from community consensus and analog modeling, not from a clinical trial. Treat the plotter curve for this compound as a reasonable approximation, not measured truth.

Use the peak-trough estimator to see how twice-weekly dosing keeps serum levels relatively stable with this half-life assumption.

DHB vs tren: side effects

This is one of the most common comparison searches, so here is the honest breakdown.

Trenbolone is notorious for a specific side-effect cluster: night sweats, insomnia, anxiety and mood changes (“tren rage”), prolactin elevation, the “tren cough” immediately after injection, and cardiovascular strain. It is rated moderately to severely hepatotoxic depending on ester, and it carries a distinct mental-health burden that many users find intolerable.

DHB does not share most of these. It does not interact with prolactin pathways, does not cause night sweats, and there is no “DHB cough” in the literature. The main documented complaints are:

• Injection-site pain: this is the headline issue. DHB injections are widely reported as painful, with swelling, redness, and irritation at the injection site. The compound’s physical properties (concentration, carrier, the molecule itself) make it irritating to tissue. Diluting with a less irritating compound or using lower concentrations helps, but this is a real practical problem.
• Lipid suppression: like most non-aromatizing androgens, DHB suppresses HDL (“good” cholesterol) and shifts the lipid profile in an unfavorable direction.
• Hematocrit elevation: non-aromatizing compounds tend to raise hematocrit more than those that aromatize, which thickens blood and raises cardiovascular risk.
• HPTA suppression: as a potent anabolic, DHB shuts down natural testosterone production. A proper PCT protocol is needed after any run.

The overall side-effect profile is considered milder than trenbolone, but that is a low bar. Trenbolone has one of the harshest side-effect profiles of any anabolic. DHB being “milder than tren” does not mean it is mild.

DHB vs Primobolan: results

The other big comparison is against Primobolan (methenolone). Both are non-aromatizing, both are considered “dry” compounds, and both appeal to users looking for lean gains without water retention.

Feature	DHB (1-testosterone)	Primobolan (methenolone)
Origin	DHT derivative of boldenone	DHT derivative, own class
Aromatization	None	None
Anabolic potency	Reported as high	Reported as mild to moderate
Typical result	Lean mass, strength, hardness	Slow, quality lean tissue
Injection pain	Severe, well-documented	Minimal
Human PK data	Almost none	Limited but exists
Detection window	Not well characterized	Long (metabolites persist)

The community consensus is that DHB produces more dramatic strength and mass gains than Primobolan, but at the cost of much worse injection-site pain. Primobolan is the gentler, slower option. DHB is the more aggressive option for users who can tolerate the injection issues.

That said, the evidence base for these comparative claims is anecdotal. There are no head-to-head trials. If you see claims that DHB is “2x stronger than Primo” or similar, treat them as community estimates, not measured findings.

Practical considerations and monitoring

If someone chooses to use DHB, the monitoring needs match the pharmacology:

• Lipids: check total cholesterol, HDL, LDL, and triglycerides before, during, and after. The HDL suppression from non-aromatizing androgens is real and dose-dependent.
• Hematocrit: monitor throughout. If it exceeds 52 to 54%, dose reduction or phlebotomy may be needed.
• Blood pressure: track it. Lipid shifts and hematocrit elevation both raise cardiovascular risk.
• Liver enzymes: rated mild hepatotoxicity, but AST, ALT, and GGT should still be checked.
• Testosterone: DHB suppresses natural production. Plan for PCT (post-cycle therapy) with agents like Nolvadex or Clomid.

The injection-site pain deserves specific attention. Some users dilute DHB with another compound (like testosterone or an injectable B-complex) to reduce the concentration per milliliter. Others rotate sites more frequently. Warm compresses and massage after injection help some users. The pain is real and is the most common reason people abandon the compound.

Detection

DHB is detectable by anti-doping labs, though the specific long-term metabolites and detection windows are not as well characterized as for more common compounds. WADA bans it. Anyone subject to drug testing should assume a detection window of weeks to months depending on dose, duration, and the specific metabolites the lab screens for. Do not rely on the half-life for clearance estimates; detection windows are driven by metabolites, not the parent compound.

Frequently asked questions

Is DHB stronger than Primobolan?

Community reports consistently describe DHB as more potent for strength and lean mass than Primobolan. There are no head-to-head clinical trials to confirm this. Primobolan is generally considered the milder, slower compound, while DHB is the more aggressive option. The trade-off is that DHB causes substantially worse injection-site pain.

Does DHB cause injection-site pain?

Yes, this is the most widely reported side effect. DHB injections are frequently described as painful, with swelling, redness, and irritation at the injection site. This is attributed to the compound’s physical properties. Diluting the concentration, rotating sites, and using warm compresses can help manage it, but for some users the pain is severe enough to discontinue use.

How does DHB compare to trenbolone for side effects?

DHB has a reportedly milder side-effect profile than trenbolone. It does not cause night sweats, prolactin issues, mood changes, or the post-injection cough associated with tren. However, DHB still carries the standard risks of non-aromatizing androgens (lipid suppression, hematocrit elevation, HPTA suppression) plus its own severe injection-site pain. “Milder than tren” is a low bar, not an endorsement.

What is the half-life of DHB?

The dataset models a half-life of roughly 9 days (216 hours), based on community consensus and analog modeling rather than controlled study. There is no published human pharmacokinetic study establishing the true half-life. Twice-weekly injection of the cypionate ester is the documented community protocol for keeping serum levels stable.

Does DHB aromatize or cause water retention?

No. DHB is 5-alpha-reduced, which means it cannot aromatize to estrogen. It produces a dry, non-estrogenic effect with no water retention. This is the main reason it is compared to Primobolan, Masteron, and other dry compounds rather than to aromatizing ones like testosterone or Dianabol.

Sources

• Llewellyn, W. ANABOLICS (11th ed.). Used as the reference for Cmax calibration and dose ranges; source note acknowledges limited published PK data for 1-testosterone.
• World Anti-Doping Agency. Prohibited List. wada-ama.org.
• Community and harm-reduction literature on injection-site reactions and monitoring protocols for non-aromatizing androgens.